Test Price
2,800 AEDโ Home Collection Available
๐ Results in 3 to 4 Weeks
CAV3 Gene Familial Hypertrophic Cardiomyopathy (HCM) Genetic Test in UAE | 2,800 AED | DNA Labs UAE
Executive Summary & Core Metrics
This advanced CAV3 gene analysis using next-generation sequencing delivers precise molecular diagnosis for familial hypertrophic cardiomyopathy, supported by premium home collection logistics and expert post-test clinical guidance. Fully compliant with UAE healthcare regulations and international quality standards.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The CAV3 gene test employs next-generation sequencing to detect pathogenic variants associated with familial hypertrophic cardiomyopathy. Full gene coverage, copy number variation detection, and a minimum read depth of 100ร ensure robust and definitive molecular results for at-risk individuals and families. This test is specifically designed for patients with a personal or family history suggestive of hypertrophic cardiomyopathy who require confirmatory genetic analysis.
| Feature | Our CAV3 Genetic Test | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Precision / Method | NGS โ full gene coverage, CNV detection, 100ร read depth | Sanger โ limited to coding exons, no CNV analysis |
| Diagnostic Sensitivity | 99.9% for SNVs, indels, and deep intronic variants | ~90โ95% (misses nonโcoding variants) |
| Turnaround Time | 3 to 4 Weeks | 4 to 6 Weeks |
Physician Insight & Safety Protocols
โUnderstanding your genetic predisposition through this CAV3 gene analysis is a powerful step toward proactive cardiac care. A positive finding is not a definitive diagnosis but a critical indicator that warrants comprehensive clinical evaluation and family cascade screening. Always interpret results within the context of your complete medical and family history.โ
โ Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory Notice
Medication Warning
Do not discontinue prescribed medication without consulting your doctor. Genetic test results should complement, not replace, your current treatment plan.
Exclusion Criteria & Emergency Red Flags
- Inability to provide informed consent (guardian consent and pre-test genetic counseling mandatory for minors per Federal Decree-Law No. 4 of 2016 on Medical Liability).
- Absence of a pre-test genetic counseling session with a certified clinical geneticist.
- Active severe psychiatric condition impeding understanding of test implications.
- Emergency Red Flags: If you experience sudden chest pain, palpitations, fainting (syncope), or severe shortness of breath, seek emergency care immediately.
Patient FAQ & Clinical Guidance
1. What is the CAV3 gene and how does it relate to hypertrophic cardiomyopathy?
The CAV3 gene produces caveolin-3, a protein essential for heart muscle cell membrane organization. Pathogenic variants in CAV3 cause familial hypertrophic cardiomyopathy with elevated risk of arrhythmia and sudden cardiac death. This test identifies those at-risk individuals, enabling early intervention and tailored family screening.
2. Who should consider this genetic test in the UAE?
Any person with a family history of hypertrophic cardiomyopathy, unexplained cardiac events, or athletes undergoing pre-participation cardiac screening should consider this test after expert genetic counselling. First-degree relatives of a known CAV3 variant carrier are strongly advised to pursue testing.
3. How is the sample collected, and what is the turnaround time?
A simple blood draw or buccal swab is collected at your home by a certified phlebotomist via our VIP mobile phlebotomy service with temperature-controlled cold-chain logistics. The complete NGS analysis and clinical interpretation are delivered within 3 to 4 weeks.
UAE Regulatory & Data Privacy Adherence
โ ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139) | Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) | Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields | Federal Decree-Law No. 4 of 2016 on Medical Liability | DHA Licensed Facility 1143
Clinical & Logistical Metadata
| Test Name | CAV3 Gene Familial Hypertrophic Cardiomyopathy (HCM) Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type / Matrix | Peripheral whole blood (EDTA) or buccal swab |
| Methodology Used | Next-Generation Sequencing (NGS) โ full gene coverage, CNV detection, 100ร read depth |
| ICD-10-CM Code | I42.1 (Obstructive hypertrophic cardiomyopathy) |
| LOINC Code | 21636-6 (Hypertrophic cardiomyopathy genetic testing panel) |
| DHA Facility License & Address | License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
Preparation Required
["No specific fasting required", "No medication or diet changes needed prior to sample collection"]
Medically Reviewed by Dr. Lina Osama Zaki Quteineh
All content reviewed by qualified professionals for accuracy.
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians